Celltrion
068270.KS
£84.65
Share price
-0.06%
Change (1 day)
-15.11%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Market capitalization of Celltrion (068270.KS)
Market cap: £18.42 Billion
As of April 2025 Celltrion has a market cap of £18.42 Billion. This makes Celltrion the world's 794th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Celltrion from 2007 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | £18.42 B | -12.37% |
| 2024 | £21.02 B | -19.98% |
| 2023 | £26.27 B | 75.36% |
| 2022 | £14.98 B | -12.76% |
| 2021 | £17.17 B | -48.07% |
| 2020 | £33.08 B | 117.86% |
| 2019 | £15.18 B | -22.39% |
| 2018 | £19.56 B | 2.73% |
| 2017 | £19.04 B | 116.17% |
| 2016 | £8.81 B | 61.54% |
| 2015 | £5.45 B | 134.46% |
| 2014 | £2.32 B | 7.57% |
| 2013 | £2.16 B | -19.56% |
| 2012 | £2.68 B | 14.44% |
| 2011 | £2.34 B | 5.2% |
| 2010 | £2.23 B | 174.03% |
| 2009 | £0.81 B | 48.09% |
| 2008 | £0.55 B | 5752.02% |
| 2007 | £9.4 M |
End of Day market cap according to different sources
On Apr 16th, 2025 the market cap of Celltrion was reported to be:
£18.51 Billion
£18.51 Billion